GAMCO Investors’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-18,900
| Closed | -$41.8K | – | 874 |
|
|
2023
Q2 | $41.8K | Buy |
18,900
+3,400
| +22% | +$7.05K | ﹤0.01% | 846 |
|
|
2023
Q1 | $39.4K | Hold |
15,500
| – | – | ﹤0.01% | 873 |
|
|
2022
Q4 | $29K | Sell |
15,500
-34,000
| -69% | -$84.8K | ﹤0.01% | 876 |
|
|
2022
Q3 | $127K | Hold |
49,500
| – | – | ﹤0.01% | 858 |
|
|
2022
Q2 | $96K | Hold |
49,500
| – | – | ﹤0.01% | 882 |
|
|
2022
Q1 | $147K | Buy |
49,500
+500
| +1% | +$1.88K | ﹤0.01% | 886 |
|
|
2021
Q4 | $220K | Buy |
49,000
+15,000
| +44% | +$71.2K | ﹤0.01% | 868 |
|
|
2021
Q3 | $165K | Buy |
+34,000
| New | +$187K | ﹤0.01% | 886 |
|
|
2021
Q2 | – | Sell |
-13,000
| Closed | -$92K | – | 938 |
|
|
2021
Q1 | $92K | Hold |
13,000
| – | – | ﹤0.01% | 903 |
|
|
2020
Q4 | $81K | Sell |
13,000
-1,200
| -8% | -$7.06K | ﹤0.01% | 878 |
|
|
2020
Q3 | $77K | Sell |
14,200
-35,000
| -71% | -$173K | ﹤0.01% | 862 |
|
|
2020
Q2 | $257K | Sell |
49,200
-6,500
| -12% | -$28.9K | ﹤0.01% | 761 |
|
|
2020
Q1 | $175K | Hold |
55,700
| – | – | ﹤0.01% | 806 |
|
|
2019
Q4 | $224K | Hold |
55,700
| – | – | ﹤0.01% | 853 |
|
|
2019
Q3 | $241K | Hold |
55,700
| – | – | ﹤0.01% | 833 |
|
|
2019
Q2 | $222K | Sell |
55,700
-2,300
| -4% | -$10.9K | ﹤0.01% | 869 |
|
|
2019
Q1 | $311K | Sell |
58,000
-1,000
| -2% | -$6.46K | ﹤0.01% | 750 |
|
|
2018
Q4 | $303K | Buy |
+59,000
| New | +$448K | ﹤0.01% | 713 |
|
GAMCO Investors's PRTK Position: Q3 2023 in Review
GAMCO Investors sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q3 2023, closing a stake of 18,900 shares — an estimated $41.8K sold.
GAMCO Investors first reported a position in PRTK in Q4 2018 and held it in 18 quarters. The position peaked at $311K in Q1 2019. 0 funds tracked by Wall St. Rank hold PRTK as of Q3 2023.
- GAMCO Investors reported no remaining Paratek Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
- GAMCO Investors sold 18,900 Paratek Pharmaceuticals, Inc. shares in Q3 2023, an estimated $41.8K.
- GAMCO Investors first reported a position in Paratek Pharmaceuticals, Inc. in Q4 2018 and held it in 18 quarters.
- GAMCO Investors's Paratek Pharmaceuticals, Inc. position peaked at $311K in Q1 2019.
- 0 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q3 2023.
Based on GAMCO Investors's 13F filing for Q3 2023, filed 8 Nov 2023.